RPMI 1640 originally was used for growth of human lymphocytes. This medium is formulated for use in a 5% carbon dioxide atmosphere. RPMI 1640 allows the cultivation of human T/B-lymphocytes, bone marrow cells, and hybridoma cells, amongst others, when supplemented with serum or an equivalent substitute.